NCT05117775
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +6 more
- Locations
-
- Savan Research S.L Madrid, Spain
Clinical trial condition
Squamous Cell Carcinoma of Head and Neck
Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.
1,367 public trials
360 recruiting studies
Squamous Cell Carcinoma of Head and Neck trial results
NCT05120947
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- Froedtert & the Medical College of Wisconsin Milwaukee, Wisconsin, United States
Completed
The Efficacy of Induction and Adjuvant Camrelizumab Combined With Chemoradiation for LA-HNSCC
NCT05213884
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China
- Chongqing University Three Gorges Hospital Wanzhou, Chongqing Municipality, China
- The Affiliated Hospital of Southwest Medical University Luzhou, Sichuan, China
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, HNSCC, +7 more
- Locations
-
- Oncology Consultants Huston, Texas, United States
Completed
Phase Ib of L-NMMA and Pembrolizumab
NCT03236935
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +30 more
- Locations
-
- Houston Methodist Cancer Center Houston, Texas, United States
NCT05077709
- Conditions
- Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +16 more
- Locations
-
- City of Hope Duarte, California, United States
- UC Davis Cancer Center Sacramento, California, United States
- University of California San Diego San Diego, California, United States
- Mid Florida Hematology and Oncology Center Orange City, Florida, United States
Completed
Camrelizumab in Combination With Cetuximab and Chemotherapy for Relapsed/Metastatic HNSCC Patients
NCT05673577
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +5 more
- Locations
-
- Fudan University Shanghai, China
Completed
Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
NCT03370276
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Carcinoma, +14 more
- Locations
-
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
- Emory University School of Medicine Atlanta, Georgia, United States
- The Ohio State University Columbus, Ohio, United States
NCT02510859
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- Service ORL et de chirurgie cervico- faciale Caen CHU, France
Completed
Safety Study of Afatinib and Postoperative Radiation Therapy to Treat Head and Neck Cancer
NCT01783587
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Mount Sinai Medical Center/Icahn School of Medicine at Mount Sinai New York, United States